Carol Pollock

Dec 18, 2024 | nature.com | Carol Pollock

Sodium–glucose co-transporter 2 inhibitors have revolutionized the management of chronic kidney disease. However, long-term data regarding their use are lacking. The post-trial follow-up study to EMPA-KIDNEY provides several insights into how the effects of these powerful medications might be optimized, but several key questions remain unanswered.

Feb 19, 2024 | radcliffecardiology.com | Anne W. Alexandrov |James Burton |David C. Wheeler |Carol Pollock

AHA ISC 2024 — Dr Anne Alexandrov (University of Tennessee Health Science Center, US) joins us to summarise the key findings from the Zero Degree Head Positioning in Hyperacute Large Artery Ischaemic Stroke (ZODIAC) trial (NCT03728738). ZODIAC is a prospective randomized open blinded endpoint (PROBE) clinical trial investigating head positioning in hyperacute LVO ischemic stroke treatment.

Sep 28, 2023 | mdpi.com | Long Nguyen |Long Nguyễn |Carol Pollock |Sonia Saad

1. IntroductionDevelopmental programming is a mechanism, whereby health complications in adulthood are attributed to physiological stress that occurs during or even before gestation [1,2].